This journal flipped to open access on September 1, 2017.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely available online in perpetuity under a Creative Commons licence.
The APC for this journal is currently 2100 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Innate Immunity is a highly ranked, peer-reviewed open access journal and is the official journal of the International Endotoxin & Innate Immunity Society (IEIIS).
The aim of the journal is to provide a single, interdisciplinary forum for the dissemination of new information on innate immunity in humans, animals, and plants.
Thus, the journal welcomes manuscripts from researchers actively working on all aspects of innate immune responses, including humoral, cellular, and clinical topics. The journal specifically welcomes submissions focusing on the interaction of cells with endotoxin- and exotoxin-related ligands from Gram-positive and Gram-negative bacteria, viruses and plants, assessing the responses by multi-omics approaches such as, but not exclusively, RNASeq, lipidomic and metabolomic responses. It also accepts manuscripts describing new immunologically active bacterial, viral, fungal, parasitic, and plant components, their receptors, signalling pathways, and induced mediators, as long as they describe a clear link between the identified and described component and the innate immune response.
Furthermore, Innate Immunity encourages submissions that take advantage of a wide array of model systems, including but not limited to humans, rodents, insects, plants and beyond, to probe the underlying principles involved. However, Innate Immunity is not accepting data that were generated in cell lines only. It has become increasing clear that such data vary widely between the same cell line used in different labs, and that the data are often impacted by the transformation of the cells used to generate the cell line. Thus, data generated in cell lines will only be accepted as part of a manuscript that assesses their biological relevance by reproducing the data in primary test systems, such as primary cells, organ cultures or indeed in vivo systems.
The journal includes Original Research articles, Research Notes, Reviews and Mini-reviews. In addition, Innate Immunity has introduced a new article type ‘Technical Note’ which gives authors the opportunity to describe novel methods, reagents, software, codes or databases, techniques, or significant improvements to established protocols. More information can be found in the manuscript submission guidelines under Article Types.
If you have any questions relating to the appropriateness of your manuscript for submission to Innate Immunity, please contact the Editor-in-Chief, Prof Dirk Werling at firstname.lastname@example.org
|Dirk Werling||The Royal Veterinary College, UK|
|Patricia M. Sanchez Carballo||Research Center Borstel, Germany|
|Alan S. Cross||University of Maryland, USA|
|Amanda Gibson||Aberyswyth University, UK|
|Shoichiro Kurata||Tohoku University, Japan|
|Bernd Lepenies||University of Veterinary Medicine Hannover, Germany|
|Christine Neupert||Malcisbo AG, Switzerland|
|Mark Pfuhl||King’s College London, UK|
|Neal Silverman||UMass Chan Medical School, USA|
|Sven Brandau||University Hospital Essen, Germany|
|Albrecht Bufe||Ruhr University Bochum, Germany|
|Jean-Marc Cavaillon||Institut Pasteur, France|
|Dipshikha Chakravortty||Indian Institute of Science, India|
|Pedro Esteves||Universidade do Porto, Portugal|
|Eugen Faist||Ludwig Maximillian University, Germany|
|Koichi Fukase||Osaka University, Japan|
|Andrew Gewirtz||Georgia State University, USA|
|Amy Hise||Case Western Reserve University, USA|
|Johannes Hübner||Klinikum der Universität München|
|Simon Jackson||University of Plymouth, UK|
|Roman Jerala||Kemijski Institut - KI, Slovenia|
|Carsten Kirschning||University Hospital Essen, Germany|
|Paul Kosma||University of Natural Resources and Life Sciences, Vienna, Austria|
|Martin Krönke||Cologne University, Germany|
|Coen Kuijl||VU University Medical Center, Netherlands|
|Shoichi Kusumoto||Osaka, Japan|
|Simon MacKenzie||University of Stirling, UK|
|Kensuke Miyake||The University of Tokyo, Japan|
|Antonio Molinaro||University of Naples Federico II, Italy|
|Sven Müller-Loennies||Research Center Borstel, Germany|
|Robert S Munford||National Institute of Allergy and Infectious Diseases, USA|
|Mari-Anne Newman||University of Copenhagen, Denmark|
|Nades Palaniyar||Toronto, Canada|
|Francesco Peri||University of Milano-Bicocca, Italy|
|Dana Philpott||Toronto, Canada|
|Gerald B Pier||Boston, USA|
|Pirkko Pussinen||Helsinki, Finland|
|Mikael Skurnik||Helsinki, Finland|
|M Stephen Trent||Austin, USA|
|Klaus Überla||Universitätsklinikum Erlangen, Germany|
|Stefanie Vogel||Bethesda, USA|
|Mamoru Watanabe||Tokyo, Japan|
|Dirk Werling||The Royal Veterinary College, UK|
|Chris Whitfield||Guelph, Canada|
|Takashi Yokochi||Aichi, Japan|
|Alla Zamyatina||University of Natural Resources and Life Sciences, Austria|
|Holm Zerbe||München, Germany|
Manuscript Submission Guidelines: Innate Immunity
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
- Editorial policies
4.1 Peer review policy
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
- On acceptance and publication
8.1 SAGE Production
8.2 Online publication
8.3 Promoting your article
- Further information
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/INI to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Innate Immunity will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal
Innate Immunity is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
The APC for this journal is currently $2,100 USD. The APC will be $2,200 USD starting from 1st January 2023.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Before submitting your manuscript to Innate Immunity, please ensure you have read the Aims & Scope.
Innate Immunity considers the following article types:
In addition, Innate Immunity has introduced a new article type ‘Technical Note’ which gives authors the opportunity to describe novel methods, reagents, software, codes or databases, techniques, or significant improvements to established protocols.
Please find more information regarding the different forms the ‘Technical Note’ can take:
Genome sequences and chemical characterisation of new ligands. Innate Immunity considers papers that announce a sequence of a newly identified ligand that stimulates the innate immune response. The manuscript should provide detailed information about the organism the ligand has identified, and a brief description of the identification method used to identify the ligand, with an emphasis on the detailed methodology and protocols used to characterize the ligand genetically and chemically. Accession numbers associated with publicly available data, for both raw reads and assemblies, should be provided with submission. Announcement of genome sequences, and raw data associated with them, will not be considered for publication until this is publicly available via GenBank, RefSeq and TPA, as well as records from SwissProt, the Protein Information Resource, the Protein Research Foundation, and the Protein Data Bank. By publishing a resource in Innate Immunity, authors agree, within reason, to make their materials available to the community, barring security restrictions. Authors are encouraged to submit their new ligands in expression plasmids or deposit them in a public repository such as Addgene.
Databases and software: Innate Immunity considers papers that announce the development of novel databases and software related to the identification of new innate immune stimulating ligands. The manuscript must describe the implementation of the software used. For a full 10 years following publication, the authors must make the software available to the community either via Weblink if hosted on a specific server or via the GitHub repository. In this case, the authors must also be available for technical support.
Protocols and workflows: Innate Immunity considers manuscripts describing novel wet or dry lab protocols used to generate and identify substances that stimulate an innate immune response in mammals, fish, birds, insects and plants. The protocol and required reagents and software used need to be described in detail, and authors must ensure that all protocols/reagents/software are available to the wider community, either though purchase or public repository before the manuscript will be considered.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
3.3.1 Making your article discoverable
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online
Following a preliminary triage to eliminate submissions unsuitable for Innate Immunity all papers are sent out for review. The covering letter is important. To help the Editor in his preliminary evaluation, please indicate why you think the paper suitable for publication. If your paper should be considered for fast-track publication, please explain why.
All manuscripts are reviewed initially by the Editor and only those papers that meet the scientific and editorial standards of the journal, and fit within its aims and scopes, will be sent for outside review. Of these manuscripts, each is reviewed by at least two referees, one of which will be an Editorial Advisory Board member. All manuscripts are reviewed as rapidly as possible, and an editorial decision is generally reached within 4-6 weeks of submission. Innate Immunity utilizes a single-anonymize peer review process in which the reviewer’s name and information is withheld from the author.
As part of the submission process you will be asked to provide the names of three peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.
Innate Immunity is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Innate Immunity can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
4.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
4.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
Innate Immunity requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Innate Immunity to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
Innate Immunity conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
Innate Immunity and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
5.1.2 Prior publication
If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Innate Immunity publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
Title page: The title page should give the following information: (1) title of the article (in bold), as short and informative as possible, without any abbreviation; (2) one first name, initials (if applicable) and last name of each author; (3) address of the department or institution to which the work should be attributed; (4) name, telephone, fax number and email address of the author responsible for correspondence and to whom the proof, invoices for coloured figures (if applicable) and the publication charge, and e-prints should be sent.
Abstract: This should consist of no more than 200 words summarizing the contents of the article. Please do not subdivide, e.g. Background, Aim, Results, Conclusion, or similar. It is important, especially for indexing services, that the abstract should be intelligible without reference to the full text or to literature references. The abstract must stand alone, and it should be presumed that the reader has some knowledge of the subject but has not read the paper. Except in the case of a standard abbreviation (see 6.), do not abbreviate a term when used only once. When used more than once, do abbreviate and define.
Keywords: Authors are requested to supply three to five keywords (words or phrases) in alphabetical order.
The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online
Text: Headings should be appropriate to the nature of the paper. In general, those for experimental papers should follow the usual conventions. Reviews can be subdivided as the author desires; the use of headings enhances readability.
The sugar absolute configuration symbols L and D are written as small capitals. The configuration symbols (R) and (S) are written in brackets and italicized. The g for g force is italicized. Otherwise, authors should apply the rules and recommendations of IUBMB and IUPAC, i.e. for abbreviation of chemical names, nomenclature of chemical compounds and enzymes, etc. With regard to the nomenclature of carbohydrates, authors are asked to follow recommendations published in Carbohydr Res 1997; 297: 1-92. The use of LIPID MAPS Initiative (Fahy E, et al., J Lipid Res 2005; 46: 839-862) is strongly recommended for the use of lipid classification, nomenclature and structural representation.
Proprietary names: Proprietary names of drugs, instruments etc. should be indicated by the use of initial capital letters.
Abbreviations and units: All measurements should be expressed in metric units. For more detailed recommendations, authors may consult the Royal Society of Medicine publication entitled Units, Symbols and Abbreviations: A Guide for Biological and Medical Editors and Authors or USA equivalent.
References: The accuracy of references is the responsibility of the author. Innate Immunity adheres to the SAGE Vancouver reference style. Review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in color will appear in color online.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
Innate Immunity is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/INI to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author via our editing portal SAGE Edit, or by email to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Innate Immunity editorial office as follows:
Prof Dirk Werling